new high, page-5

Hi guys im in....

Eureka report has a really good article on it recommending an out perform...


The key things i like and take from the report are:
- outperform
- valuation 0.39
- 25% annual rev growth projection
- growth to be limited by supply constraints not demand (what a lovely problem to have)
-high conversion of NPAT to Free Cash Flow
- Net Cash
- Industry growth of net 20%
-So an out perform of 5% on an industry growth of 20% seems reasonably safe projections given supply contraints are the limitation...
- Costs for software development to reduce from $7m to $3m
-Converion to software / hardware 50:50 to drive revenue growth
- Takeover prospects from HIL put a pretty good security blanket under the price.

And from my perspective the ability to slash admission times by so much gives it a massive unique selling point that will drive mass sales volumes. Hospitals cant resist anything that reduces costs at the same time as increasing beds available. Its an irresistible proposition.

I have family in health and the biggest problems are budget, beds available and waiting for beds to be cleared. This solves all 3 in one hit...